Abstract: BACKGROUND AIMS: Glutamine supplementation has been associated with reduced mortality, infections and hospital length of stay in critically ill patients and patients undergoing major surgery. We carried out a meta-analysis to examine randomized clinical trial (RCT)-based evidence of these effects. METHODS: Based on a systematic database search, RCTs published since 1990 were included if they evaluated the effect of parenteral glutamine supplementation against a background of parenteral nutrition. Enteral (tube) feeding in a proportion of patients was allowable. Information on RCT methodology, quality and outcomes was extracted. Random effects meta-analysis followed the DerSimonian-Laird approach. RESULTS: Forty RCTs were eligible for meta-analysis. Parenteral glutamine supplementation was associated with a non-significant 11% reduction in short-term mortality (RR = 0.89; 95% CI, 0.77-1.04). Infections were significantly reduced (RR = 0.83; 95% CI, 0.72-0.95) and length of stay was 2.35 days shorter (95% CI, -3.68 to -1.02) in the glutamine arms. Meta-analysis results were strongly influenced by one recent trial. An element of publication bias could not be excluded. CONCLUSION: Parenteral glutamine supplementation in severely ill patients may reduce infections, length of stay and mortality, but substantial uncertainty remains. Unlike previous meta-analyses, we could not demonstrate a significant reduction in mortality. 
ICU admission status
: Subgroup analyses by patient type. Bg mortality, background mortality risk defined as the risk of death in the control group; BW, body weight; LOS, length of stay; WMD, weighted mean difference; a Score points ascribed to the studies in the quality assessment according to a modified Jadad score. 
Multivariate meta-regression analysis -short-term mortality
Meta-regression Number of obs = 22 REML estimate of between-study variance tau2 = 0 % residual variation due to heterogeneity I-squared_res = 0.00% Proportion of between-study variance explained Adj R-squared = 100.00% Joint test for all covariates Model F(2,19) = 5.79 With Knapp-Hartung modification Prob > F = 0.0109 Table S4 : Multivariate meta-regression model for weighted mean difference of hospital length of stay. Adj., adjusted; Coef., coefficient; Conf., confidence; High gln dose, glutamine dose >0.20 g/kg body weight/day; High qual. study, high quality study (see legend to Table S1 ); I-squared_res, residual I 2 ; obs, observations; REML, restricted maximum likelihood; Sev. disease, higher disease severity (background mortality >0.20); Std. Err., standard error; t, t statistic; WMD, weighted mean difference. NOTE: N influenced by availability of covariate information. Figure S3 : Funnel plots of short-term mortality, 6-month mortality, infectious complications and LOS. SE, standard error; WMD, weighted mean difference.
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